2025 first_quarter Filing
Q1Lobbying Activities
Issues pertaining to FY 25 and FY 26 funding for the CDC, including the Prevention Research Centers. Issues pertaining to FY 25 and FY 26 funding for the NIH, including the Fogarty International Center. Issues pertaining to FY 25 and FY 26 funding for new National Hepatitis C Elimination Program. Issues pertaining to FY 25 and FY 26 funding for HRSA, including the Public Health Workforce Loan Repayment Program and the Public Health Training Centers. Issues pertaining to FY 25 and FY 26 funding for AHRQ. Issues pertaining to FY 25 and FY 26 funding for Global Health Programs at USAID and Department of State.
Issues Pertaining to NIH Facilities and Administrative (F&A) Costs Cap Issues Pertaining to Removal of CDC Data Sets and Suspension of Scientific Publications Issues Pertaining to Hepatitis C Elimination Act Issues Pertaining to the Plastic Health Research Act Issues Pertaining to Public Health Workforce and HHS Restructuring Plan Issues Pertaining to Gun Violence Prevention